| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Theravance Biopharma, Inc. | EVP, Gen. Counsel, Secretary | Ordinary Shares | 277,831 | $2,858,881 | $10.29 | 20 Aug 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TBPH | Theravance Biopharma, Inc. | 20 Aug 2021 | 1 | -$60,513 | 4 | EVP, Gen. Counsel, Secretary | 24 Aug 2021, 19:03 |
| TBPH | Theravance Biopharma, Inc. | 20 May 2021 | 1 | -$76,718 | 4 | EVP, Gen. Counsel, Secretary | 24 May 2021, 18:18 |